Ceasing to be a substantial holder
04 October 2018 This is a notice regarding an individual or entity...
Read MoreCLINUVEL Confirms AGM Date
03 October 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read MoreCLINUVEL Initiates Variegate Porphyria Proof of Concept Study
01 October 2018 CLINUVEL PHARMACEUTICALS LTD today announced that it has reached...
Read MoreNasdaq International Designation Virtual Investor Conference Presentation
20 September 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read MoreAppendix 3B
11 September 2018 New issue announcement, application for quotation of additional securities...
Read MoreInvestor Presentation NewsMakers Conference
10 September 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read MoreUS FDA Update
05 September 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read MoreChange in substantial holding
04 September 2018 Enclosed is a notice of change of interests of...
Read MoreCLINUVEL declares first time dividend
29 August 2018 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...
Read More